18 April 2024 - The federal Liberal-NDP coalition government recently announced it would work with the provinces to fund universal prescription ...
11 April 2024 - A recent study published by the Canadian Health Policy Institute examined the availability and wait times ...
9 April 2024 - Target Zero is a new initiative that aims to improve the time to access for patients ...
4 April 2024 - More than one billion people worldwide live with migraine, and the World Health Organization classifies migraine ...
3 April 2024 - Bausch Health Canada today announced the first public drug plan listings for Uceris (budesonide) aerosol foam ...
5 March 2024 - Multiple formulary listings are a step forward to ensuring that post-menopausal women have access to medicines ...
29 February 2024 - On Rare Disease Day — a day when the international community raises awareness about rare conditions ...
6 February 2024 - Knight Therapeutics announced today the launch of Bijuva (oestradiol and progesterone) capsules in Canada. ...
6 February 2024 - Public reimbursement for Vascepa is now available in Ontario, Quebec, British Columbia, Saskatchewan, New Brunswick, Northwest Territories, ...
16 January 2024 - Fenfluramine costs more than $3,000 a month and is not approved by Health Canada. ...
27 November 2023 - Of the 2556 prescription drugs marketed by 89 companies in the study period, 256 (10.0%) had a ...
7 November 2023 - Mitsubishi Tanabe Pharma Canada today announced that Radicava oral suspension (edaravone) is now covered under the Prince ...
29 August 2023 - Mitsubishi Tanabe Pharma Canada today announced that Radicava oral suspension (edaravone) is now covered under the New ...
7 August 2023 - People diagnosed with ALS are usually given two to five years to live. ...
24 July 2023 - New Brunswick lists Albrioza on its drug benefit formulary, becoming the fourth province to provide public ...